Fundraising Fox
Verastem
NASDAQ: VSTMNeedham, US · Founded 2010 · Massachusetts corporation · 180 employees on LinkedIn · 8 known investors
Find your way into Verastem
Sign up to see every warm intro you have to Verastem
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Verastem team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients. The company focuses on oncology therapeutics including small molecules and monoclonal antibodies targeting pathways such as RAS, KRAS, and immune modulation.
Founders & leadership
Verastem was founded in 2010 by Robert Weinberg and RICHARD ALDRICH.
Investors · 8
How we know: Bessemer Venture Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Cardinal Partners's portfolio page · Not right? Tell us
How we know: Foresite Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Longwood Fund's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Viking Global's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$108.7M disclosed across 3 rounds · 2014–2020
▶$100MraisedMar 2020 · 21 investors · PharmaceuticalsRule 506(c)
- BRIAN STUGLIKExecutive Officer, Director
- BRUCE WENDELDirector
- ERIC ROWINSKYDirector
- ALISON LAWTONDirector
- TIMOTHY BARBERICHDirector
- MICHAEL KAUFFMANDirector
- DAN PATERSONExecutive Officer
- GINA CONSYLMANDirector
- ROB GAGNONExecutive Officer
- Offering amount
- $100M
- Amount sold
- $100M
- Sales commissions
- $6M
- Placement agents
- H.C.WAINWRIGHT & CO., LLC, JEFFERIES LLC, CANTOR FITZGERALD & CO.
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$4.8MraisedJan 2020 · 4 investors · PharmaceuticalsRule 506(c)
- TIMOTHY BARBERICHDirector
- ALISON LAWTONDirector
- ERIC ROWINSKYDirector
- BRUCE WENDELDirector
- GINA CONSYLMANDirector
- MICHAEL KAUFFMANDirector
- AMY C. CAVERSExecutive Officer
- CATHY CAREWExecutive Officer
- JONATHAN PACHTERExecutive Officer
- ROB GAGNONExecutive Officer
- BRIAN STUGLIKExecutive Officer, Director
- DAN PATERSONExecutive Officer
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$3.9MraisedMar 2014 · 1 investors · BiotechnologyRule 506(b)
- MICHAEL KAUFFMANDirector
- ROBERT FORRESTERExecutive Officer, Director
- JOHN GREENExecutive Officer
- CHRISTOPH WESTPHALExecutive Officer, Director
- DAN PATERSONExecutive Officer
- HENRI TERMEERDirector
- JONATHAN PACHTERExecutive Officer
- LOUISE PHANSTIELDirector
- RICHARD ALDRICHDirector
- MONICA SINGHExecutive Officer
- JOANNA HOROBINExecutive Officer
- STEPHEN SHERWIN, M.D.Director
- JOHN K. CLARKEDirector
- ALISON LAWTONDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Verastem.
Frequently asked questions
- What does Verastem do?
- Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients. The company focuses on oncology therapeutics including small molecules and monoclonal antibodies targeting pathways such as RAS, KRAS, and immune modulation.
- Who founded Verastem?
- Verastem was founded by Robert Weinberg, RICHARD ALDRICH in 2010.
- Who are Verastem's investors?
- Verastem's investors include Bessemer Venture Partners, Cardinal Partners, Foresite Capital, Lightstone Ventures, Longwood Fund, Oberland Capital, Viking Global, OrbiMed.
- How much funding has Verastem raised?
- Verastem has disclosed $108.7M raised across 3 rounds.
- Where is Verastem headquartered?
- Verastem is headquartered in Needham, US.